Masters Capital Management’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-200,000
Closed -$6.95M 61
2020
Q4
$6.95M Sell
200,000
-800,000
-80% -$22.6M 0.41% 49
2020
Q3
$17.3M Sell
1,000,000
-200,000
-17% -$3.48M 1.15% 29
2020
Q2
$19.7M Buy
1,200,000
+200,000
+20% +$3.04M 2.23% 19
2020
Q1
$9.07M Buy
1,000,000
+331,710
+50% +$6.68M 1.05% 27
2019
Q4
$14.2M Buy
668,290
+361,590
+118% +$8.02M 0.81% 31
2019
Q3
$7.04M Sell
306,700
-93,300
-23% -$2.13M 0.42% 47
2019
Q2
$9.71M Buy
+400,000
New +$8.23M 0.47% 44

Other funds holding ADNT

Masters Capital Management's ADNT Position: Q1 2021 in Review

Masters Capital Management sold out of Adient (ADNT) in Q1 2021, closing a stake of 200,000 shares — an estimated $6.95M sold.

Masters Capital Management first reported a position in ADNT in Q2 2019 and held it in 7 quarters. The position peaked at $19.7M in Q2 2020. 300 funds tracked by Wall St. Rank hold ADNT as of Q1 2021.

  • Masters Capital Management reported no remaining Adient position as of Q1 2021 after selling out during the quarter.
  • Masters Capital Management sold 200,000 Adient shares in Q1 2021, an estimated $6.95M.
  • Masters Capital Management first reported a position in Adient in Q2 2019 and held it in 7 quarters.
  • Masters Capital Management's Adient position peaked at $19.7M in Q2 2020.
  • 300 funds tracked by Wall St. Rank held Adient as of Q1 2021.

Based on Masters Capital Management's 13F filing for Q1 2021, filed 17 May 2021.